KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Clostridium difficile (2003–2004 + Israel)

• Clostridium difficile
• Clostridium difficile (1982 + USA)
• Clostridium difficile (1982–2004)
• Clostridium difficile (1983–2004 + USA)
• Clostridium difficile (1987 + Italy)
• Clostridium difficile (1991 + France)
• Clostridium difficile (1991 + USA)
• Clostridium difficile (1997 + Belgium)
• Clostridium difficile (2000 + Italy)
• Clostridium difficile (2003–2004 + Israel)
• Clostridium difficile (2004 + Canada)
• Clostridium difficile (2004 + USA)
• Clostridium difficile (630)
• Clostridium difficile (ATCC 43255)
• Clostridium difficile (cd1)
• Clostridium difficile (cd14)
• Clostridium difficile (cd8)
• Clostridium difficile (Europe)
• Clostridium difficile (GAI 10029)
• Clostridium difficile (GAI 10038)
• Clostridium difficile (JCM 1296)
• Clostridium difficile (MC119)
• Clostridium difficile (MC141)
• Clostridium difficile (MC146)
• Clostridium difficile (metronidazole-resistant)
• Clostridium difficile (metronidazole-susceptible + vancomycin-susceptible)
• Clostridium difficile (North America)
• Clostridium difficile (vancomycin-intermediate)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8